DRMAW vs PHM
Dermata Therapeutics Inc. Warrant (DRMAW) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
Dermata Therapeutics Inc. Warrant (DRMAW) common stock listed on NASDAQ.
PulteGroup Inc (PHM) is a residential construction company listed on US.
DRMAW does not have a complete income-statement cache yet.
Latest reported PHM revenue for 2026-06-30 was $7.39B. Net income was $819.0M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
DRMAW currently screens at market cap $0. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the DRMAW and PHM stock pages for the full models.
Not investment advice.